Alendronate is a first-line therapy of postmenopausal women with osteoporosis in Slovenia

被引：0
|
作者：
Hren, R
Cokolic, M
机构：
[1] Univ Ljubljana, Ljubljana 1000, Slovenia
[2] Teaching Hosp Maribor, Maribor 2000, Slovenia
来源：
BONE | 2002年 / 30卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B49
引用
收藏
页码：49S / 49S
页数：1
相关论文
共 50 条
  • [31] iPTH levels in postmenopausal women with osteoporosis treated with alendronate.
    Massari, F
    Zanchetta, JR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S470 - S470
  • [32] In postmenopausal women with osteoporosis, romosozumab followed by alendronate reduced fractures vs alendronate alone
    Hirsch, Calvin
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (02) : JC3 - JC3
  • [33] Alendronate in the treatment of postmenopausal osteoporosis
    Hosking, DJ
    Favus, M
    Yates, AJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 27 - 35
  • [34] Influence of the Osteogenomic Profile in Response to Alendronate Therapy in Postmenopausal Women with Osteoporosis: A Retrospective Cohort Study
    Vega, Alejandra Villagomez
    Nava, Jorge Ivan Gamez
    Gonzalez, Francisco Ruiz
    Romero, Misael Perez
    Rangel, Walter angel Trujillo
    Arana, Ismael Nuno
    GENES, 2023, 14 (02)
  • [35] Randomised study of anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women
    Vergote, I
    Bonneterre, J
    Thürlimann, B
    Robertson, J
    Krzakowski, M
    Mauriac, L
    Koralewski, L
    Webster, A
    Steinberg, M
    von Euler, M
    EUROPEAN JOURNAL OF CANCER, 2000, 36 : S84 - S85
  • [36] Individualizing therapy to prevent postmenopausal osteoporosis: A comparison of hormone therapy, alendronate, and raloxifene
    Col, NF
    Pauker, SG
    Goldberg, RJ
    Eckman, MH
    Orr, RK
    Ross, EM
    Wong, JB
    MEDICAL DECISION MAKING, 1998, 18 (04) : 467 - 467
  • [37] Differential effects of teriparatide and alendronate on bone parameters in postmenopausal women with osteoporosis
    McClung, MR
    Martin, JS
    Meunier, PJ
    Miller, PD
    Haddock, L
    Bandeira, F
    Szejnfled, V
    Donley, DW
    Eriksen, EF
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S5 - S5
  • [38] Effect of three years of oral alendronate treatment in postmenopausal women with osteoporosis
    Tucci, JR
    Tonino, RP
    Emkey, RD
    Peverly, CA
    Kher, U
    Santora, AC
    AMERICAN JOURNAL OF MEDICINE, 1996, 101 (05): : 488 - 501
  • [39] Treatment of osteoporosis in postmenopausal women: Alendronate Vs intranasal calcitonin.
    Rosen, CJ
    Bonnick, SL
    Miller, PD
    McClung, M
    Wasnich, RD
    Weiss, SR
    Woodson, GC
    Schnitzer, TJ
    Lenihan, JP
    Ross, RP
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S400 - S400
  • [40] Factors Affecting Discontinuation of Alendronate Treatment in Postmenopausal Japanese Women With Osteoporosis
    Iwamoto, Jun
    Miyata, Atsushi
    Sato, Yoshihiro
    Takeda, Tsuyoshi
    Matsumoto, Hideo
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2009, 72 (12) : 619 - 624
12345